AU5689400A - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- AU5689400A AU5689400A AU56894/00A AU5689400A AU5689400A AU 5689400 A AU5689400 A AU 5689400A AU 56894/00 A AU56894/00 A AU 56894/00A AU 5689400 A AU5689400 A AU 5689400A AU 5689400 A AU5689400 A AU 5689400A
- Authority
- AU
- Australia
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9914022 | 1999-06-17 | ||
GBGB9914022.0A GB9914022D0 (en) | 1999-06-17 | 1999-06-17 | Chemical compounds |
PCT/GB2000/002315 WO2000078751A2 (en) | 1999-06-17 | 2000-06-14 | Compounds for use in treatment of neurological disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5689400A true AU5689400A (en) | 2001-01-09 |
Family
ID=10855472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU56894/00A Abandoned AU5689400A (en) | 1999-06-17 | 2000-06-14 | Chemical compounds |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1198463A2 (ja) |
JP (1) | JP2003502421A (ja) |
AU (1) | AU5689400A (ja) |
GB (1) | GB9914022D0 (ja) |
WO (1) | WO2000078751A2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007072146A1 (en) | 2005-12-19 | 2007-06-28 | Pfizer Japan Inc. | Chromane substituted benzimidazoles and their use as acid pump inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5030656A (en) * | 1990-03-30 | 1991-07-09 | Basf K&F Corporation | Methods of using compositions comprising (s)-emopamil for use in treating spinal cord trauma |
FR2687401B1 (fr) * | 1992-02-18 | 1994-05-20 | Meram Laboratoires | Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant. |
AU717431B2 (en) * | 1996-07-01 | 2000-03-23 | Schering Corporation | Muscarinic antagonists |
-
1999
- 1999-06-17 GB GBGB9914022.0A patent/GB9914022D0/en not_active Ceased
-
2000
- 2000-06-14 JP JP2001504917A patent/JP2003502421A/ja active Pending
- 2000-06-14 AU AU56894/00A patent/AU5689400A/en not_active Abandoned
- 2000-06-14 EP EP00942181A patent/EP1198463A2/en not_active Withdrawn
- 2000-06-14 WO PCT/GB2000/002315 patent/WO2000078751A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000078751A2 (en) | 2000-12-28 |
WO2000078751A3 (en) | 2001-03-08 |
GB9914022D0 (en) | 1999-08-18 |
JP2003502421A (ja) | 2003-01-21 |
EP1198463A2 (en) | 2002-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002222228A1 (en) | Chemical compounds | |
AU2001284584A1 (en) | Chemical compounds | |
AU5413600A (en) | Compounds | |
AU2001262886A1 (en) | Chemical compounds | |
GB9907658D0 (en) | Chemical compounds | |
GB9902461D0 (en) | Chemical compounds | |
AU2001228638A1 (en) | Chemical compounds | |
GB9909409D0 (en) | Chemical compounds | |
AU5052199A (en) | Chemical compounds | |
AU5637499A (en) | Chemical compounds iii | |
AU1746401A (en) | Compounds | |
GB9903861D0 (en) | Chemical compounds | |
AU6008000A (en) | Chemical compounds-ii | |
AUPQ319799A0 (en) | Chemical methods | |
AU1872900A (en) | Chemical compounds | |
GB9900078D0 (en) | Chemical compounds | |
AU5050899A (en) | Chemical compounds | |
AU5119400A (en) | Compounds | |
AU6006000A (en) | Chemical compounds-iii | |
AU5689400A (en) | Chemical compounds | |
AU6168900A (en) | Compounds | |
AU2668000A (en) | Bis-styrylbiphenyl compounds | |
GB9914015D0 (en) | Chemical compounds | |
GB9914024D0 (en) | Chemical compounds | |
GB9908355D0 (en) | Chemical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |